Intersect ENT is a leading brand that specializes in bioabsorbable, sustained drug release platforms to enhance patient care. Their innovative technologies provide effective and less invasive solutions for millions of people suffering from chronic rhinosinusitis. With a commitment to transforming patient care, they offer a range of integrated products that are not only highly efficient but also cost-effective.

One of their notable products is PROPEL, a localized steroid-releasing sinus implant. It helps to improve patient outcomes by providing targeted sinus relief and preventing the recurrence of nasal polyps. The PROPEL range includes PROPEL Mini and PROPEL Contour, each designed to cater to specific patient needs.

Intersect ENT ensures the safety and efficacy of their products, providing comprehensive instructions for use and information leaflets for patients. They prioritize privacy and adhere to strict terms and conditions. With a strong focus on research and development, Intersect ENT is dedicated to advancing medical technology to benefit patients worldwide.

Through their cutting-edge solutions and trademarks like INTERSECT ENT and PROPEL, they continue to make a significant impact in the field of sinus care